These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 23020229

  • 1. Smoking, von Willebrand factor and ADAMTS-13 in healthy males.
    Al-Awadhi AM, Jadaon MM, Alsayegh FA, Al-Sharrah SK.
    Scand J Clin Lab Invest; 2012 Dec; 72(8):614-8. PubMed ID: 23020229
    [Abstract] [Full Text] [Related]

  • 2. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J, Elmariah S, Aledort LM, Dlott J, Stelzer P, Halperin JL, Kini AS, Sharma SK.
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR, Kang J, Restle DJ, Zhang DM, Shabahang C, Acker MA, Atluri P.
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A, Adekile A, Marouf R.
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
    Mannucci PM, Capoferri C, Canciani MT.
    Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
    [Abstract] [Full Text] [Related]

  • 7. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
    Al-Awadhi A, Adekile A, Marouf R.
    Acta Haematol; 2021 Jul; 144(2):182-189. PubMed ID: 32987383
    [Abstract] [Full Text] [Related]

  • 8. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.
    Karakaya B, Tombak A, Serin MS, Tiftik N.
    Hematology; 2016 Jun; 21(5):295-9. PubMed ID: 26872106
    [Abstract] [Full Text] [Related]

  • 9. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
    Liu L, Ling J, Ma Z, Yuan Q, Pan J, Yang H.
    Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
    [Abstract] [Full Text] [Related]

  • 10. Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support.
    Bartoli CR, Dassanayaka S, Brittian KR, Luckett A, Sithu S, Siess T, Raess DH, Spence PA, Koenig SC, Dowling RD, D'Souza SE.
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1634-43. PubMed ID: 24139617
    [Abstract] [Full Text] [Related]

  • 11. ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment.
    Marcucci R, Cesari F, Cinotti S, Paniccia R, Gensini GF, Abbate R, Gori AM.
    Thromb Res; 2008 May; 123(1):130-6. PubMed ID: 18603284
    [Abstract] [Full Text] [Related]

  • 12. Changes in plasma von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina.
    Fuchigami S, Kaikita K, Soejima K, Matsukawa M, Honda T, Tsujita K, Nagayoshi Y, Kojima S, Nakagaki T, Sugiyama S, Ogawa H.
    Thromb Res; 2008 May; 122(5):618-23. PubMed ID: 18295305
    [Abstract] [Full Text] [Related]

  • 13. Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings.
    Dassanayaka S, Slaughter MS, Bartoli CR.
    ASAIO J; 2013 May; 59(2):123-9. PubMed ID: 23438773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.